Benign parotid tumoursBMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7478.1299 (Published 02 December 2004) Cite this as: BMJ 2004;329:1299
- Mark McGurk (firstname.lastname@example.org), professor
- Salivary Gland Service, Department of Oral and Maxillofacial Surgery, Guy's, King's and St Thomas's Hospital Trust, London SE1 9RT
All surgical disciplines have moved towards subspecialisation with the development of less invasive procedures and reduction in surgical morbidity. The difficulty with salivary tumours is that they are rare and have a long clinical course that requires follow up data for a decade or more. Prospective randomised trials have therefore not been undertaken, and progress happens slowly, with new generations of surgeons building on the experience of their peers.
Improved methods of assessment (magnetic resonance imaging, computed tomography, ultrasound, and fine needle aspiration biopsy) have had a major impact on salivary gland surgery because of increased confidence in distinguishing benign from malignant tumours. Of discrete lumps, only 5% will prove to be malignant, and over half …